Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Regulatory press release

GENT: Mandatory notification of trade

Gentian Diagnostics
Moss, 28 October 2025

Gentian Diagnostics ASA ("Gentian") has today been notified that the following
transaction has been completed by a primary insider in Gentian:

Matti Heinonen, Chief Executive Officer and primary insider in Gentian, has
purchased 5,000 shares in Gentian at NOK 54.86 per share. Mr. Heinonen owns
5,000 shares and 100,000 options after this transaction.


PDMR notification pursuant to the EU Market Abuse Regulation Article 19 is
attached.

This information is subject to the disclosure requirements pursuant to Section
5-12 of the Norwegian Securities Trading Act, EU Market Abuse Regulation Article
19 and Euronext Oslo Rule Book II.

For further information, please contact: Njaal Kind, Group CFO,
njaal.kind@gentian.no, +47 91 90 65 25
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.